Detalhe da pesquisa
1.
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
Pharmacol Res
; 173: 105911, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34560251